Diabetes News and Research

Latest Diabetes News and Research

Diabetes WA calls for greater recognition of diabetes impact on Aboriginal Communities

On National Close the Gap Day (Thursday 16 March), Diabetes WA is calling for greater recognition of the disproportionate impact of diabetes on Aboriginal Communities in Western Australia. Aboriginal West Australians are at far greater risk of diabetes and diabetes-related complications than any other community in the State.

20 Mar 2023

New WHO report identifies five core national targets for managing diabetes

A new report for the World Health Organization has identified five core national targets for UN member states aimed at reducing diabetes risk and ensuring that people with diabetes have equitable access to comprehensive and affordable care and prevention.

20 Mar 2023

What role does dysbiosis play in Parkinson's disease?

The current study, published in the journal Revue Neurologique, is based on the hypothesis that dysbiosis, or unhealthy variations in the gut and oral microbiota, is a key component of PD pathogenesis.

19 Mar 2023

Biomarkers that can predict long COVID symptoms

The current study offered novel insights into the different biological factors that might contribute to long COVID.

19 Mar 2023

California picks generic drug company Civica to produce low-cost insulin

Gov. Gavin Newsom on Saturday announced the selection of Utah-based generic drug manufacturer Civica to produce low-cost insulin for California, an unprecedented move that makes good on his promise to put state government in direct competition with the brand-name drug companies that dominate the market.

19 Mar 2023

Loss of a beta cell subset might contribute to type 2 diabetes

Multiple types of beta cells produce insulin in the pancreas, helping to balance blood sugar levels. Losing a particularly productive type of beta cell may contribute to the development of diabetes, according to a new study by Weill Cornell Medicine investigators.

17 Mar 2023

Benefiting the health of people with diabetes: The WHO Global Diabetes Compact targets

Researchers described the targets of the World Health Organization's (WHOs) Global Diabetes Compact to improve the health outcomes for all individuals affected by this fatal, non-communicable disease.

17 Mar 2023

Phase 2 clinical trial investigates the effectiveness of innovative procedure to control Type 2 diabetes

More than 37 million Americans have diabetes, and approximately 90-95% have Type 2 diabetes.

16 Mar 2023

AI-based drug interaction prediction technology analyzes the interaction between Paxlovid ingredients

KAIST (President Kwang Hyung Lee) announced on the 16th that an advanced AI-based drug interaction prediction technology developed by the Distinguished Professor Sang Yup Lee's research team in the Department of Biochemical Engineering that analyzed the interaction between the PaxlovidTM ingredients that are used as COVID-19 treatment and other prescription drugs was published as a thesis.

16 Mar 2023

The US remains a grim leader in preterm births. Why? And can we fix it?

Tamara Etienne's second pregnancy was freighted with risk and worry from its earliest days — exacerbated by a first pregnancy that had ended in miscarriage.

16 Mar 2023

Physical exercise programs tend to be easier to stick with when prescribed via mobile digital devices

Physical exercise programmes tend to be more effective and easier to stick with when they have been prescribed via mobile digital devices rather than in person or without technological support.

16 Mar 2023

Artificial pancreas technology improves blood glucose control in young children with type 1 diabetes

Artificial pancreas technology improved blood glucose control in young children between ages 2 and 5 with type 1 diabetes, according to the results of the Pediatric Artificial Pancreas (PEDAP) Trial, a 13-week randomized controlled trial conducted at three pediatric diabetes centers across the United States.

15 Mar 2023

The relationship between intestinal microbiome dysbiosis and atherosclerosis

Researchers investigate the impact of intestinal microbiota dysbiosis on atherosclerotic cardiovascular disease incidence.

15 Mar 2023

How does soy consumption affect the risk of type 2 diabetes and cardiovascular diseases?

A higher intake of plant protein could effectively improve metabolic health and lower CVD mortality. Recently, scientists in China reviewed existing literature and conducted a meta-analysis to understand the association between increased soy consumption and the risk of T2D and CVDs. This review is available in the journal Nutrients.

15 Mar 2023

Diabetes News and Research

Latest Diabetes News and Research

Diabetes WA calls for greater recognition of diabetes impact on Aboriginal Communities

New WHO report identifies five core national targets for managing diabetes

What role does dysbiosis play in Parkinson's disease?

Biomarkers that can predict long COVID symptoms

California picks generic drug company Civica to produce low-cost insulin

Loss of a beta cell subset might contribute to type 2 diabetes

Benefiting the health of people with diabetes: The WHO Global Diabetes Compact targets

Phase 2 clinical trial investigates the effectiveness of innovative procedure to control Type 2 diabetes

AI-based drug interaction prediction technology analyzes the interaction between Paxlovid ingredients

The US remains a grim leader in preterm births. Why? And can we fix it?

Physical exercise programs tend to be easier to stick with when prescribed via mobile digital devices

Artificial pancreas technology improves blood glucose control in young children with type 1 diabetes

The relationship between intestinal microbiome dysbiosis and atherosclerosis

How does soy consumption affect the risk of type 2 diabetes and cardiovascular diseases?

Mediterranean diet associated with reduction in woman's risks of cardiovascular disease and death

Researchers shine new light on a potential target for the treatment of diabetic nephropathy

Researchers identify a potential treatment to prevent severe COVID-19 in high-risk patients

Higher plasma caffeine levels may reduce adiposity and risk of type 2 diabetes

How does the gut microbiome affect muscle strength?

Study identifies link between oral and gut microbiomes and depression

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diabetes News and Research

Latest Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in